Singapore markets closed

Longboard Pharmaceuticals, Inc. (LBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.38-1.43 (-6.29%)
At close: 04:00PM EDT
22.00 +0.62 (+2.92%)
After hours: 07:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 831.02M
Enterprise value 783.00M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)20.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -13.80

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3143.70%
S&P500 52-week change 322.38%
52-week high 328.15
52-week low 33.60
50-day moving average 320.10
200-day moving average 312.19

Share statistics

Avg vol (3-month) 3521.29k
Avg vol (10-day) 3372.04k
Shares outstanding 533.61M
Implied shares outstanding 638.88M
Float 85.67M
% held by insiders 11.09%
% held by institutions 165.98%
Shares short (15 Apr 2024) 44.92M
Short ratio (15 Apr 2024) 410.3
Short % of float (15 Apr 2024) 417.12%
Short % of shares outstanding (15 Apr 2024) 412.66%
Shares short (prior month 15 Mar 2024) 43.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.30%
Return on equity (ttm)-30.04%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -62.9M
Net income avi to common (ttm)-57.95M
Diluted EPS (ttm)-2.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)321.04M
Total cash per share (mrq)37.19
Total debt (mrq)3.98M
Total debt/equity (mrq)1.27%
Current ratio (mrq)31.43
Book value per share (mrq)8.07

Cash flow statement

Operating cash flow (ttm)-52.95M
Levered free cash flow (ttm)-32.51M